“…After that, individuals become asymptomatic EBV carriers. The exact mechanism of EBV cancer induction is still unknown, though increased titers of EBV antibodies, high content of viral DNA in blood plasma of patients, and monoclonality of viral genome in giant Reed-Sternberg cells in Hodgkin's lymphoma shows the role of the virus in tumour development (Gurtsevitch et al, 2018). It was found, that in Burkitt lymphoma, which is non-Hodgkin's one, the viral protein Epstein-Barr nuclear antigen 1 (EBNA1) is expressed; proteins EBNA-1, LMP-1, and LMP-2 are expressed in diffuse large Bcell lymphoma, in NK/T cell lymphoma, and Hodgkin's lymphoma; nine EBV proteins are expressed in patients with heavy immunodeficiency (after organ transplantation or HIV infection) (Shannon-Lowe et al, 2017).…”